United States Senate Select Committee on Nutrition and Human Needs

Senator Mark Warner Visits ReAlta Life Sciences’ Biotech Research Facility, Highlights Importance of Rare Disease Innovation

Retrieved on: 
목요일, 10월 12, 2023

ReAlta Life Sciences (“ReAlta”), Inc., a clinical mid-stage biotech company focused on harnessing the power of the immune system to address life-threatening diseases, was pleased to welcome Senator Mark R. Warner (D-Va) for an in-depth visit with the ReAlta management team, members of the ReAlta board of directors, and local investors on October 2, 2023.

Key Points: 
  • ReAlta Life Sciences (“ReAlta”), Inc., a clinical mid-stage biotech company focused on harnessing the power of the immune system to address life-threatening diseases, was pleased to welcome Senator Mark R. Warner (D-Va) for an in-depth visit with the ReAlta management team, members of the ReAlta board of directors, and local investors on October 2, 2023.
  • View the full release here: https://www.businesswire.com/news/home/20231012073021/en/
    Sen. Mark Warner (D-Va) with ReAlta CEO Dr. Ulrich Thienel, board chairman Edward Heidt, Jr., CMO Dr. Kenji Cunnion, CSO Dr. Neel Krishna, and ReAlta staff.
  • “ReAlta is on the cutting edge of research in a variety of fronts – from COVID to birth asphyxia,” said Sen. Mark R. Warner.
  • The company looks forward to continuing to push the boundaries of what is possible in the fight against life-threatening rare diseases.

Expensive dental care worsens inequality. Is it time for a Medicare-style 'Denticare' scheme?

Retrieved on: 
일요일, 7월 2, 2023

Private dental care is increasingly unaffordable, and millions of Australians go without the treatment they need.

Key Points: 
  • Private dental care is increasingly unaffordable, and millions of Australians go without the treatment they need.
  • The potentially avoidable costs to the health-care system and to people’s quality of life has led to increased pressure for a Medicare-style universal insurance scheme for dental care (Denticare) or the inclusion of dental care into Medicare.
  • Affordable and available dental care is crucial to addressing inequality in Australia.

Why wasn’t dental included in Medicare in the first place?

    • There is, however, little to no evidence on the extent to which the Whitlam government pushed for dental to be included or how much it was opposed by dentists.
    • It seems it was not on the agenda when Medicare was restored by the Hawke government.
    • Secondly, the provision of public dental health services – often linked to dental hospitals and dental schools – has long been seen (especially by Coalition governments) as the responsibility of states and territories.

A short history

    • This section gives the Commonwealth the power to legislate and fund these services but it’s not obligated to do so.
    • The Whitlam government was the first to provide national funding and direction to these state-based programs through the Australian School Dental Program.

The barriers to universal dental care

    • These figures don’t factor in the savings made to health-care costs due to preventable dental cavities and gum disease (estimated by the Australian Dental Association at $818 million per year) and reduced productivity.
    • The other approach is to reduce costs by limiting the number of people covered and/or the number and type of services covered.
    • Means testing access to Medicare Benefits Schedule items for dental care is risky; it could easily lead to means testing of access to other MBS items.

There’s more we can do

    • Researchers have described the Chronic Dental Disease Scheme (introduced by the Howard government) as as “the most expensive and controversial public dental policy in Australian history”.
    • As a 2012 analysis showed, it blew out its budget and did not result in dental health improvements.
    • It’s worth noting many of the preventive actions needed to address obesity (for example, encouraging breast feeding and limiting sugary beverages) will also improve dental health.
    • Read more:
      How to fill the gaps in Australia's dental health system

‘Battered and broken. I must get out’: what staff told us about teaching and working in universities today

Retrieved on: 
일요일, 6월 25, 2023

It is a byproduct of the neoliberal “reforms” introduced here in the 1980s and which have affected every aspect of university work.

Key Points: 
  • It is a byproduct of the neoliberal “reforms” introduced here in the 1980s and which have affected every aspect of university work.
  • We see this time and again when universities cite financial losses and implement staff cuts.
  • Submissions to the Australian Senate Select Committee on Job Security suggested underpayment of casual teaching staff in Australian universities is rampant.

‘Constantly drowning’

    • In their stories, we hear about how the intensification of casual workloads leads to forced choices between poor quality teaching or working unpaid hours.
    • We hear how staff feel trapped in a cycle of exhaustion, futility, guilt and hopelessness.
    • Without rapid and real change, we fear a future where the university’s role of nurturing critical thinkers is vastly diminished.

The public good

    • As another wrote:
      Students expect to study full-time and achieve good grades while working full-time because the neoliberal complex implies this is possible.
    • Students expect to study full-time and achieve good grades while working full-time because the neoliberal complex implies this is possible.
    • Universities no longer prioritise academics using their expertise to innovate and investigate for the public good.
    • Instead, they are pressured to pursue externally-funded research, tailored to suit the appetite of a government or prevailing public opinion.

Funding for critical thinking

    • We need to see a return to the idea of funding education as a public good in and of itself (granted, a radical idea under neoliberalism).
    • It’s no accident that the focus of frequent cuts by corporate-minded universities is on disciplines that teach critical thinking skills.
    • And we need proper funding for research that isn’t tied to government policy or ideology.

Distinguished Alumni Lecture Series founders secure the program’s future

Retrieved on: 
화요일, 2월 21, 2023

He was the founding chair of the President’s Council, chair of his 25th and 50th class reunions, and a champion of the Newman Alumni Center.

Key Points: 
  • He was the founding chair of the President’s Council, chair of his 25th and 50th class reunions, and a champion of the Newman Alumni Center.
  • In 1995, StuBloch and his wife, Ambassador Julia Chang Bloch, made a gift to the University to establish the Distinguished Alumni Lecture Series (DALS).
  • Their goal was to create a forum to highlight the wealth of talent, accomplishment, and social and cultural impact of the University and its alumni.
  • The series is now called The Stu Bloch ’64 Distinguished Alumni Lecture Series.

BioAge Hosting Webcast to Discuss Newly Announced Phase 1b Data Demonstrating BGE-105 Significantly Improves Muscle Atrophy in Older Volunteers on Bed Rest and Detail Phase 2 Plans

Retrieved on: 
수요일, 12월 14, 2022

William Evans, PhD is Adjunct Professor of Human Nutrition at UC Berkeley and Medicine (Geriatrics) at Duke University.

Key Points: 
  • William Evans, PhD is Adjunct Professor of Human Nutrition at UC Berkeley and Medicine (Geriatrics) at Duke University.
  • Previously, he was President of the Muscle and Health Division at KineMed and VP and Head of GlaxoSmithKlines Muscle Metabolism Discovery Performance Unit.
  • Phase 1b trial data released to date demonstrate that in healthy volunteers 65 and older on 10-day strict bed rest, BGE-105 prevented muscle atrophy as reflected by improvements in multiple parameters, including the dimensions of leg muscles, muscle quality, and muscle protein synthesis.
  • BioAge has multiple programs targeting muscle, immune, and brain aging, including the clinical-stage apelin receptor agonist BGE-105 and a differentiated CNS-penetrant NLRP3 inhibitor.

The Cost of Colic Due to CMA Just Went Down: Perrigo Nutrition Introduces First and Only U.S. Store Brand Hypoallergenic Infant Formula

Retrieved on: 
수요일, 9월 15, 2021

Perrigo Nutrition, maker of all Store Brand Infant Formula, has introduced a U.S. Store Brand Hypoallergenic Infant Formula that compares to the nutrition of name-brand hypoallergenic formulas Nutramigenand Similac Alimentum.1

Key Points: 
  • Perrigo Nutrition, maker of all Store Brand Infant Formula, has introduced a U.S. Store Brand Hypoallergenic Infant Formula that compares to the nutrition of name-brand hypoallergenic formulas Nutramigenand Similac Alimentum.1
    Now, for the first time, parents can choose a store brand formula that is clinically tested to manage cow's milk allergies (CMA) and helps babies avoid colic due to CMA.2The new formula is the first and only store brand (generic) extensively hydrolyzed infant formula that meets the American Academy of Pediatrics (AAP) Committee on Nutrition's guidelines for hypoallergenic formulas.
  • More than half of those moms (52 percent) would have also purchased a lower-cost generic store brand hypoallergenic infant formula option if it were available.
  • Our new Store Brand Hypoallergenic Infant Formula gives families a more affordable option in a category where there has been little choice.
  • Perrigo Nutrition, makers of all Store Brand Infant Formula, helps make lives better by providing quality, affordable self-care products.